• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Metabolite to parent drug concentration ratio as a function of parent drug extraction ratio: cases of nonportal route of administration.

作者信息

Lane E A, Levy R H

出版信息

J Pharmacokinet Biopharm. 1981 Aug;9(4):489-96. doi: 10.1007/BF01060891.

DOI:10.1007/BF01060891
PMID:7310646
Abstract

The ratio of metabolite to parent drug concentration (Cm/Cp) of a medium or high extraction ratio (E greater than 0.1) drug administered intravenously has been shown to depend on intrinsic clearance of drug by other metabolic routes (CLr,int) as well as on organ blood flow (Q). In contrast, for a low extraction ratio drug given intravenously or for any drug given by a portal route, this ratio is equal to the ratio of formation clearance (CLf,int) and metabolite clearance (CLm,int). The sensitivity of Cm/Cp to changes in CLr,int and CLf,int has been analyzed quantitatively. It was shown to be dependent on the fraction metabolized to that particular metabolite (fm).

摘要

相似文献

1
Metabolite to parent drug concentration ratio as a function of parent drug extraction ratio: cases of nonportal route of administration.
J Pharmacokinet Biopharm. 1981 Aug;9(4):489-96. doi: 10.1007/BF01060891.
2
The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.肝脏和肝外器官清除的药物及代谢物的代谢物曲线下面积。其对前体药物给药途径的依赖性。
Drug Metab Dispos. 1985 Jan-Feb;13(1):97-101.
3
General method for evaluating the fraction of the irreversible organ clearance due to conversion of drug to a primary metabolite.
J Pharm Sci. 1985 Jul;74(7):722-6. doi: 10.1002/jps.2600740705.
4
Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption.肠道节段性转运体和代谢酶对肠道药物吸收的影响
Drug Metab Dispos. 2003 Apr;31(4):373-83. doi: 10.1124/dmd.31.4.373.
5
Effect of a protein binding change on unbound and total plasma concentrations for drugs of intermediate hepatic extraction.蛋白结合变化对中度肝提取药物的游离和总血浆浓度的影响。
J Pharmacokinet Biopharm. 1988 Oct;16(5):529-42. doi: 10.1007/BF01062383.
6
A review of metabolite kinetics.代谢物动力学综述。
J Pharmacokinet Biopharm. 1985 Dec;13(6):633-62. doi: 10.1007/BF01058905.
7
Metabolite pharmacokinetics: the area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites.代谢物药代动力学:肾清除和肝清除药物及代谢物经不同给药途径给药后代谢物的曲线下面积和药物代谢分数率。
J Pharmacokinet Biopharm. 1981 Aug;9(4):477-87. doi: 10.1007/BF01060890.
8
Drug metabolite kinetics.药物代谢动力学。
Pharmacol Ther. 1981;15(3):521-52. doi: 10.1016/0163-7258(81)90056-5.
9
Protein binding and drug clearance.蛋白质结合与药物清除率。
Clin Pharmacokinet. 1984 Jan;9 Suppl 1:10-7. doi: 10.2165/00003088-198400091-00002.
10
Drug metabolite concentration-time profiles: influence of route of drug administration.药物代谢物浓度-时间曲线:给药途径的影响
Br J Clin Pharmacol. 1984 Apr;17(4):385-94. doi: 10.1111/j.1365-2125.1984.tb02362.x.

引用本文的文献

1
A review of metabolite kinetics.代谢物动力学综述。
J Pharmacokinet Biopharm. 1985 Dec;13(6):633-62. doi: 10.1007/BF01058905.
2
Primary, secondary, and tertiary metabolite kinetics.初级、次级和三级代谢物动力学。
J Pharmacokinet Biopharm. 1988 Oct;16(5):493-527. doi: 10.1007/BF01062382.
3
Effects of ethanol on drug and metabolite pharmacokinetics.乙醇对药物及代谢产物药代动力学的影响。

本文引用的文献

1
Interindividual differences in amitriptyline demethylation.阿米替林去甲基化的个体间差异。
Clin Pharmacol Ther. 1980 Jul;28(1):121-9. doi: 10.1038/clpt.1980.140.
2
Prediction of steady-state behavior of metabolite from dosing of parent drug.根据母体药物给药情况预测代谢物的稳态行为。
J Pharm Sci. 1980 May;69(5):610-2. doi: 10.1002/jps.2600690541.
3
Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.
Clin Pharmacokinet. 1985 May-Jun;10(3):228-47. doi: 10.2165/00003088-198510030-00003.
4
Physiological modeling of drug and metabolite: disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation.药物及代谢物的生理模型:奥沙西泮及其葡糖醛酸苷在再循环灌注小鼠肝制备物中的处置
J Pharmacokinet Biopharm. 1990 Oct;18(5):423-48. doi: 10.1007/BF01061703.
药物的肝清除率。I. “充分搅拌”模型和“平行管”模型的理论考量。肝血流量、血浆和血细胞结合以及肝细胞酶活性对肝药物清除率的影响。
J Pharmacokinet Biopharm. 1977 Dec;5(6):625-53. doi: 10.1007/BF01059688.
4
Sequential first-pass elimination of a metabolite derived from a precursor.
J Pharmacokinet Biopharm. 1979 Jun;7(3):275-90. doi: 10.1007/BF01060018.
5
Time-dependent kinetics I: Exponential autoinduction of carbamazepine in monkeys.时间依赖性动力学I:卡马西平在猴子体内的指数自诱导
J Pharm Sci. 1977 May;66(5):647-9. doi: 10.1002/jps.2600660511.
6
Kinetics of biotransformation of clonazepam to its 7-amino metabolite in the monkey.
J Pharmacokinet Biopharm. 1979 Feb;7(1):87-95. doi: 10.1007/BF01059443.
7
Pharmacokinetic description of drug interactions by enzyme induction: carbamazepine-clonazepam in monkeys.酶诱导介导的药物相互作用的药代动力学描述:猴子体内的卡马西平-氯硝西泮相互作用
J Pharm Sci. 1979 Apr;68(4):416-21. doi: 10.1002/jps.2600680406.
8
Pharmacokinetics of carbamazepine-10,11- epoxide before and after autoinduction in rhesus monkeys.
J Pharmacol Exp Ther. 1978 Sep;206(3):607-13.
9
Altered hepatic blood flow and drug disposition.肝脏血流和药物处置的改变。
Clin Pharmacokinet. 1976;1(2):135-55. doi: 10.2165/00003088-197601020-00005.